The first paediatric patient for Dimerix’s ACTION3 phase III clinical trial into a rare kidney disease has been recruited at ...

Check the time stamp on this data. Updated AI-Generated Signals for First Tr Etf Vi (FSGS) available here: FSGS. Type a few ...

Dimerix Limited (ASX:DXB), a Melbourne-based biopharmaceutical company, has started recruitment for its first paediatric ...

There is currently no cure for FSGS, which is the leading cause of kidney failure in children, and 5,400 patients are ...

Leerink Partners analyst Joseph Schwartz has maintained their bullish stance on TVTX stock, giving a Buy rating yesterday.Stay Ahead of the ...

Received 693 new patient start forms for FILSPARI® (sparsentan) in the fourth quarter of 2024; approximately $50 million in preliminary net ...

Long-term abuse of anabolic steroids can lead to focal segmental glomerulosclerosis (FSGS), according to a recent study. Although anabolic steroid abuse is known to have adverse effects on the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Opyl has entered a joint venture with X Firm to market its TrialKey platform in key markets, while Dimerix has inked another ...

Dimerix has inked an exclusive development and license agreement for development and commercialisation of its ACTION3 phase ...